Overview

Lidocaine for Diabetic Peripheral Neuropathy

Status:
Completed
Trial end date:
2018-10-17
Target enrollment:
Participant gender:
Summary
Diabetic nerve pain [painful diabetic peripheral neuropathy] is a common medical problem with few reliably effective treatments. There is some evidence that sensory testing may help determine how individuals will respond to analgesic therapy. In this study, the investigators are evaluating the relationship between sensory testing and subject response to lidocaine infusion therapy.
Phase:
N/A
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Lidocaine